Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Cerebral Palsy
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This trial will study the safety and efficacy of intravenous infusion of cultured umbilical or placental derived mesenchymal stem cells for the treatment of Cerebral Palsy
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosis of Cerebral Palsy
Locations
United States
Florida
Prodromos Stem Cell Institute
RECRUITING
Naples
Other Locations
Greece
Prodromos Stem Cell Institute
RECRUITING
Athens
Contact Information
Primary
Chadwick Prodromos, MD
care@thepsci.com
847-699-6810
Time Frame
Start Date: 2026-12
Estimated Completion Date: 2028-12
Participants
Target number of participants: 15
Treatments
Experimental: Treatment Group
Single intravenous infusion of 100 million cells
Authors
Related Therapeutic Areas
Sponsors
Leads: The Foundation for Orthopaedics and Regenerative Medicine